VP1-binding protein glucose-regulated protein 78 as an important mediator for enterovirus 71 infecting human brain

Wenying Luo1, Peng Liang2, Santhosh Puthiyakunnon3

  • 1Department of Clinical Laboratory, Affiliated Hospital of Guangdong Medical University, Zhanjiang; Department of Laboratory Medicine, School of Laboratory Medicine, Guangdong Medical University, Guangdong, China.

Abstract

Insights

Enterovirus 71 (EV71) infection involves glucose-regulated protein 78 (GRP78) binding to viral protein 1 (VP1). GRP78 mediates EV71 invasion and replication in brain endothelial cells, impacting disease progression.

Area of Science:

  • Virology
  • Cell Biology
  • Neuroscience

Background:

  • Enterovirus 71 (EV71) causes hand, foot, and mouth disease, potentially leading to severe neurological complications.
  • The precise mechanisms of EV71 invasion and replication in the central nervous system remain incompletely understood.

Purpose of the Study:

  • To identify host cell proteins involved in EV71 invasion of human brain microvascular endothelial cells (HBMECs).
  • To elucidate the role of identified proteins in the EV71 infection pathway and pathogenesis.

Main Methods:

  • Proteomic analysis (GST pull-down coupled with LC-ESI-MS/MS) to identify EV71 VP1-binding proteins in HBMECs.
  • Validation using co-immunoprecipitation, immunofluorescence, and Western blot.
  • Functional assays including gene knockdown/overexpression of GRP78 and TCID50 to assess viral replication.

Main Results:

  • Ninety-one candidate proteins binding to EV71 VP1 were identified; 78 kDa glucose-regulated protein 78 (GRP78) was validated as a key interactor.
  • GRP78 co-localized with VP1 in the cytoplasm of infected HBMECs.
  • Knockdown of GRP78 reduced EV71 replication, while its overexpression enhanced viral load.

Conclusions:

  • GRP78 is a crucial host factor mediating EV71 infection in HBMECs.
  • GRP78 plays a significant role in the replication capacity of EV71.
  • Targeting GRP78 may offer a therapeutic strategy against EV71-induced neuropathogenesis.